← Open Payments lookup

NPI 1538492319: Open Payments

NPI 1538492319. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$385 in 6 payments from 4 companies in 2025. Trend: 2023 $37 · 2024 $199 · 2025 $385

Food & beverage: $385
CompanyPaymentsAmount
SCPHARMACEUTICALS INC.2$161
Alnylam Pharmaceuticals Inc.1$125
ABIOMED2$65
Novartis Pharmaceuticals Corporation1$34

Products named: FUROSCIX, AMVUTTRA, LEQVIO.